Sexual Health & Libido
Research domain covering compounds that influence sexual arousal pathways, the hypothalamic-pituitary-gonadal axis, and reproductive endocrinology. Includes melanocortin receptor agonists, neuropeptides, and PDE5 inhibitors studied for their effects on sexual function and libido.
12 Articles on This Research Goal
Clomiphene Citrate: Evidence-Based Research Review
Clomiphene citrate (CC) is a non-steroidal triphenylethylene derivative classified as a Selective Estrogen Receptor Modulator (SERM). Originally developed for the induction of ovulation in women with anovulatory infertility, it has become a cornerstone of reproductive medicine. CC operates as a race
Tamoxifen Citrate: Evidence-Based Research Review
Tamoxifen citrate is a non-steroidal triphenylethylene derivative and the prototypic Selective Estrogen Receptor Modulator (SERM). Originally developed as a contraceptive, it has become a cornerstone in the treatment and prophylaxis of estrogen receptor-positive (ER+) breast cancer. Tamoxifen exhibi
Testosterone Enanthate: Evidence-Based Research Review
Testosterone enanthate (TE) is a long-acting esterified formulation of the primary endogenous androgen, testosterone. Since its clinical introduction in the 1950s, it has served as a cornerstone for testosterone replacement therapy (TRT) in male hypogonadism and a reference compound in clinical rese
Toremifene Citrate: Evidence-Based Research Review
Toremifene citrate is a chlorinated triphenylethylene derivative and a second-generation selective estrogen receptor modulator (SERM). Structurally analogous to tamoxifen, toremifene was developed to maintain the therapeutic efficacy of ER-antagonism in breast tissue while potentially improving the
Raloxifene: Evidence-Based Research Review
Raloxifene is a second-generation selective estrogen receptor modulator (SERM) of the benzothiophene class. Developed to address the limitations of first-generation SERMs like tamoxifen, raloxifene exhibits distinct tissue-specific effects: it acts as an estrogen receptor (ER) agonist in bone and li
Melanotan II: Ξ±-MSH Analog Pharmacology, Clinical History, and Safety Profile
Melanotan II is a synthetic analog of Ξ±-melanocyte-stimulating hormone investigated in early-phase clinical trials for tanning and sexual dysfunction. This review summarizes its clinical evidence and notable safety concerns.
PT-141 / Bremelanotide: Melanocortin Agonist for Hypoactive Sexual Desire Disorder β Regulatory and Clinical Evidence
PT-141, developed as bremelanotide, is a melanocortin receptor agonist FDA-approved (Vyleesi) for premenopausal women with hypoactive sexual desire disorder. This review summarizes the registrational clinical evidence.
BPC-157 and Tissue Repair Signaling Pathways
Comprehensive review of BPC-157 mechanisms in tissue repair, angiogenesis, and mucosal healing.
Melanocortin Receptor Agonists and Neuroendocrine Signaling
Examination of melanocortin receptor signaling and synthetic agonist research applications.
Testosterone Enanthate vs Nandrolone: Evidence-Based Comparison
Testosterone Enanthate (TE) and Nandrolone Decanoate (ND) represent the two most common injectable anabolic-androgenic steroids (AAS) used in clinical and performance-enhancing contexts. Testosterone Enanthate serves as the gold standard for hormone replacement therapy (HRT) and as a physiological b
Raloxifene vs Tamoxifen: Evidence-Based Comparison
Selective Estrogen Receptor Modulators (SERMs) are a class of compounds characterized by their ability to act as estrogen receptor (ER) agonists or antagonists in a tissue-specific manner. Tamoxifen, a first-generation triphenylethylene SERM, and Raloxifene, a second-generation benzothiophene SERM,
Tamoxifen vs Clomiphene: Evidence-Based Comparison
Tamoxifen Citrate and Clomiphene Citrate are triphenylethylene-derivative Selective Estrogen Receptor Modulators (SERMs) that have been used extensively in clinical practice for over four decades. While both compounds share a similar chemical backbone, they exhibit distinct tissue-specific activitie
13 Compounds Studied Under This Goal
Testosterone Enanthate
AASPrimary endogenous androgen esterified for sustained depot release
Read profile βDutasteride
MedicineDual 5-alpha reductase inhibitor (types I and II)
Read profile βFinasteride
MedicineType II 5-alpha reductase inhibitor; reduces DHT conversion
Read profile βAnastrozole
MedicineNonsteroidal aromatase inhibitor; blocks estrogen biosynthesis
Read profile βToremifene Citrate
SERMsTriphenylethylene SERM; tamoxifen analog with reduced endometrial risk
Read profile βRaloxifene
SERMsBenzothiophene SERM; no endometrial agonist activity
Read profile βKisspeptin
Sexual HealthUpstream regulator of GnRH neurons and the hypothalamic-pituitary-gonadal axis.
Read profile βMelanotan 2
Sexual HealthNon-selective melanocortin receptor agonist studied for tanning and libido effects.
Read profile βSildenafil
Sexual HealthPDE5 inhibitor enhancing nitric oxide-mediated vasodilation in erectile tissue.
Read profile βPT-141 (Bremelanotide)
Sexual HealthMelanocortin receptor agonist acting on CNS pathways to influence sexual arousal.
Read profile βOxytocin
Sexual HealthNeuropeptide modulating social bonding, trust, and sexual arousal via oxytocin receptors.
Read profile βClomiphene Citrate
SERMsMixed SERM used to stimulate endogenous gonadotropin release
Read profile βTamoxifen Citrate
SERMsTriphenylethylene SERM; tissue-selective estrogen antagonist/agonist
Read profile βAll compounds, protocols, and content are for research use only (RUO). This knowledge graph documents biochemical research pathways and is not a treatment guide. For laboratory and research purposes only.